Prostate cancer patients who have a more heterogeneous set of detectable circulating tumor cells are more likely to develop resistance to anti-androgen therapy, according to the results of a new study.
Men who take aspirin regularly may have a lower risk of dying from prostate cancer, according to results of a large observational study.
Progression-free survival in advanced renal cell carcinoma patients treated with cabozantinib was nearly doubled compared with those treated with everolimus, according to data from the METEOR trial.
Paid sick leave benefits could alleviate some of the financial burden patients with colorectal cancer incur during treatment and boost their job retention.
Younger women who received triptorelin to suppress ovarian function prior to chemotherapy had a greater chance of preserving fertility.
Could a new imaging technique that is able to detect the distant spread of melanoma to the lymph nodes help patients avoid potentially risky surgery?
Men with prostate cancer who carry variants in the SLCO2B1 gene have shorter time to progression and overall survival.
T-DM1 improved survival in women with HER2-positive breast cancer, even after treatment with two or more other HER2-targeted therapies including trastuzumab and lapatinib.
MRI can detect a larger tumor burden than detected by mammography alone, potentially changing treatment, according to a recently published study.
The combination of radiation therapy plus cetuximab had higher rates of acute toxicity among patients with locally advanced squamous cell carcinoma of the head and neck compared with radiation therapy plus cisplatin.